<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2022.884031</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanical Strain Induces Transcriptomic Reprogramming of Saphenous Vein Progenitors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Maselli</surname> <given-names>Davide</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1621341/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Garoffolo</surname> <given-names>Gloria</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1460165/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cassanmagnago</surname> <given-names>Giada Andrea</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1606748/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Vono</surname> <given-names>Rosa</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1799644/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ruiter</surname> <given-names>Matthijs S.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/508023/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Thomas</surname> <given-names>Anita C.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/131201/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Madeddu</surname> <given-names>Paolo</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/180616/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Pesce</surname> <given-names>Maurizio</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/189090/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Spinetti</surname> <given-names>Gaia</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/154695/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>IRCCS MultiMedica</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff2"><sup>2</sup><institution>Translational Health Sciences, Bristol Medical School, University of Bristol</institution>, <addr-line>Bristol</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff3"><sup>3</sup><institution>Unit&#x000E0; di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino IRCCS</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff4"><sup>4</sup><institution>IRCCS Humanitas Research Hospital</institution>, <addr-line>Rozzano</addr-line>, <country>Italy</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Biomedical Sciences, Humanitas University</institution>, <addr-line>Pieve Emanuele</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Shizuka Uchida, Aalborg University Copenhagen, Denmark</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Alban Longchamp, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland; Margreet R. De Vries, Leiden University Medical Center, Netherlands</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Gaia Spinetti <email>gaia.spinetti&#x00040;multimedica.it</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine</p></fn>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work and share first authorship</p></fn>
<fn fn-type="equal" id="fn003"><p>&#x02021;These authors share senior authorship</p></fn></author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>884031</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Maselli, Garoffolo, Cassanmagnago, Vono, Ruiter, Thomas, Madeddu, Pesce and Spinetti.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Maselli, Garoffolo, Cassanmagnago, Vono, Ruiter, Thomas, Madeddu, Pesce and Spinetti</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract>
<p>Intimal hyperplasia is the leading cause of graft failure in aortocoronary bypass grafts performed using human saphenous vein (SV). The long-term consequences of the altered pulsatile stress on the cells that populate the vein wall remains elusive, particularly the effects on saphenous vein progenitors (SVPs), cells resident in the vein adventitia with a relatively wide differentiation capacity. In the present study, we performed global transcriptomic profiling of SVPs undergoing uniaxial cyclic strain <italic>in vitro</italic>. This type of mechanical stimulation is indeed involved in the pathology of the SV. Results showed a consistent stretch-dependent gene regulation in cyclically strained SVPs vs. controls, especially at 72 h. We also observed a robust mechanically related overexpression of Adhesion Molecule with Ig Like Domain 2 (AMIGO2), a cell surface type I transmembrane protein involved in cell adhesion. The overexpression of AMIGO2 in stretched SVPs was associated with the activation of the transforming growth factor &#x003B2; pathway and modulation of intercellular signaling, cell-cell, and cell-matrix interactions. Moreover, the increased number of cells expressing AMIGO2 detected in porcine SV adventitia using an <italic>in vivo</italic> arterialization model confirms the upregulation of AMIGO2 protein by the arterial-like environment. These results show that mechanical stress promotes SVPs&#x00027; molecular phenotypic switching and increases their responsiveness to extracellular environment alterations, thus prompting the targeting of new molecular effectors to improve the outcome of bypass graft procedure.</p></abstract>
<kwd-group>
<kwd>saphenous vein progenitors</kwd>
<kwd>intimal hyperplasia</kwd>
<kwd>bypass graft</kwd>
<kwd>mechanosensitivity</kwd>
<kwd>AMIGO2</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="18"/>
<word-count count="9887"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Bypass grafting surgery is the main treatment for coronary artery disease, which represents the leading cause of morbidity and mortality in the industrialized western world (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Every year about one million surgical revascularization procedures are performed worldwide, and the saphenous vein (SV) remains the most widely used conduit as bypass graft (<xref ref-type="bibr" rid="B3">3</xref>). The reasons for this preference are the ease and rapid SV harvesting technique and its relatively higher length compared to radial or mammary arteries, which ensures enough supply for &#x0201C;multi-vessel&#x0201D; pathology (<xref ref-type="bibr" rid="B4">4</xref>). However, up to 20&#x02013;50% of vein grafts will require intervention within 5 years due to the development of graft stenosis caused by intimal hyperplasia (IH) (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). A better understanding of the development and progression of vein graft disease is crucial for the development of new treatments. The causes of the progressive thickening of the tunica intima of SVs, used as a coronary bypass graft, leading to IH can be partially identified in surgical mismanagement at the time of harvesting, for which recently has been introduced &#x0201C;no-touch&#x0201D; harvesting technique (<xref ref-type="bibr" rid="B7">7</xref>). A better outcome in terms of SV graft patency has been also observed when coronary artery bypass graft surgery is performed in off-pump mode (<xref ref-type="bibr" rid="B8">8</xref>). However, IH represents a long-term consequence of vein adaptation to coronary blood flow (<xref ref-type="bibr" rid="B8">8</xref>) consisting of a change from a constant pressure (5&#x02013;10 mmHg) and a steady flow, to a counter pulsed 120/80 mmHg and pulsatile flow, with a circumferential strain of 10&#x02013;15% (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Under these conditions, wall shear stress on the endothelial monolayer increases by four times, and the quasi-steady venous flow rises to a mean flow rate of 250 ml/min (<xref ref-type="bibr" rid="B10">10</xref>). Opposite to arteries, the SV wall is incompliant at high pressures resulting in a blood flow rate in SV bypass graft 5&#x02013;10 times higher than in arterial bypass graft (<xref ref-type="bibr" rid="B11">11</xref>&#x02013;<xref ref-type="bibr" rid="B13">13</xref>). As a consequence, the cells in the tunica media of the vessel are exposed to severe stretching causing an increase in proliferation, changes in the extracellular matrix, and phenotype switching (<xref ref-type="bibr" rid="B14">14</xref>&#x02013;<xref ref-type="bibr" rid="B16">16</xref>). There is an increasing number of evidence about the detrimental effect of mechanical stress on the tunica adventitia and strain-related activation of cells dwelling in the proximity of the <italic>vasa vasorum</italic> of the SV&#x00027; bypass graft (<xref ref-type="bibr" rid="B17">17</xref>&#x02013;<xref ref-type="bibr" rid="B20">20</xref>). In particular, it has been observed that paracrine signals, established in an arterial-like pressure setting, might activate a multipotent population of cells, known as saphenous vein progenitors (SVPs), which uphold differentiation capacity in aged cardiovascular patients (<xref ref-type="bibr" rid="B21">21</xref>). Of note, we recently showed that mechanical straining of SV-derived smooth muscle cells (SMCs) determines their transition from a contractile to a secretory phenotype with associated release of the matricellular protein Thrombospondin-1 (TSP-1), which consequently induces the migration and proliferation of cells with SVP phenotype (<xref ref-type="bibr" rid="B19">19</xref>). Given the importance of tissue mechanics for the progression of vein graft disease and the potential role of SVP in SV remodeling, in this study, we aimed to assess the strain-related modification of SVPs. Using an RNAseq-based approach we evaluated whether mechanical strain could induce a specific phenotypic modification of SVPs. To investigate stress-related phenotypic changes we exposed primarily isolated SVPs to <italic>in vitro</italic> uniaxial mechanical strain. Genome-wide transcriptional alterations were examined using RNA-seq and analyzed for specific function/gene regulations.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Ethics</title>
<p>The experimental investigation on human-derived SVPs was approved by the local Ethical Committee at Centro Cardiologico Monzino, IRCCS. Twelve patients recruited for the study were, females or males undergoing surgical removal of saphenous vein because of varicosity. All tissues used in the study are surgical leftovers. Exclusion criteria include concomitant neoplastic, infectious, connective tissue or inflammatory diseases, pregnancy. The Research Ethics Committee approved the study which was performed according to the ethical principles recorded in the 1964 Declaration of Helsinki and later amendments. All the subjects gave written informed consent to participate. The main clinical characteristics of the participants are included in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>.</p>
</sec>
<sec>
<title>Isolation of SVPs</title>
<p>Isolation of cells for <italic>in vitro</italic> experiments was performed as previously described, using two consecutive immunomagnetic selections to obtain CD31<sup>negative</sup>/CD34<sup>positive</sup> homogenous cell populations from saphenous vein, known as SVPs (<xref ref-type="bibr" rid="B21">21</xref>). After saphenectomy, veins were washed in PBS containing Penicillin/Streptomycin 100 U/mL (PBS &#x0002B; P/S). Saphenous vein walls were finely shredded using scissors and digested with Liberase Blendzyme 2 (Roche) diluted 2 mg/ml in Dulbecco Modified Eagle&#x00027;s Medium (DMEM, GIBCO) for 4h at 37&#x000B0;C. The minced tissue was serially filtered through 70 &#x003BC;m, 40 &#x003BC;m, and 30 &#x003BC;m cell strainers using PBS &#x0002B; P/S and then centrifuged at 300xg for 10 min at room temperature. SVPs were isolated as a result of two consecutive magnetic beads&#x02013;assisted cell sorting (MACS, MiltenyiBiotec) using a MACS MS column, according to manufacturer&#x00027;s instructions. First selection was performed using CD31 magnetic beads (MiltenyiBiotec), in which the negative fraction (CD31<sup>negative</sup>) was retained and subjected to a second magnetic sorting performed with CD34 magnetic beads (MiltenyiBiotec). After that, CD31<sup>negative</sup>/CD34<sup>positive</sup> cell fraction was centrifuged and resuspended in endothelial growth medium EGM-2 (Lonza). SVPs were plated on fibronectin/gelatin-coated plate (0.1% fibronectin - 0.4% gelatin in PBS) 3 &#x000D7; 10<sup>3</sup> cells/cm<sup>2</sup> and cultured at 37&#x000B0;C in a cell culture incubator with 5% CO<sub>2</sub>. Culture medium was replaced twice a week and once cells reached 80% confluency, they were trypsinized and split 1:3. Cells used in RNA-seq were between passage 3 and 5.</p>
</sec>
<sec>
<title>Immunocytochemical Characterization</title>
<p>To validate the identity of isolated SVPs we performed immunocytochemical characterization of the cultured cells for expression of neural/glial antigen 2 (NG2), platelet derived growth factor receptor-&#x003B2; (PDGFR&#x003B2;), GATA Binding Protein 4 (GATA4), CD31, CD146 and &#x003B1;-smooth muscle actin (&#x003B1;-SMA) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>). SVPs were seeded at 5x10<sup>3</sup> cells/cm<sup>2</sup> on fibronectin/gelatin-coated plate chamber slides, after 24 hours (h) cells were washed with PBS and fixed with 4% PFA in PBS for 15 min at room temperature. When required (GATA4 and &#x003B1;-SMA), the cells were permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) in PBS for 10 min at room temperature. Non-specific staining was blocked with 5% Fetal Bovine Serum (FBS) (GIBCO) in PBS for 30 min at room temperature. Following elimination of excess serum, the cells were exposed to the unconjugated primary antibodies at 4&#x000B0;C for 16 h: NG2 (1:100, Millipore AB-5320), PDGFR&#x003B2; (1:50, Santa Cruz SC-339), GATA4 (1:100, Abcam ab61767), CD31 (1:100, R&#x00026;D BBA7), CD146 (1:100, Abcam ab75769), &#x003B1;-SMA (1:200, Dako M0851). After washing in PBS, the appropriate fluorescent secondary antibody (Alexa Fluor) diluted 1:200 in PBS was added to the cells for 60 min at 37&#x000B0;C. Nuclei were stained with DAPI (Thermo Fisher Scientific)1 &#x003BC;g/ml for 10 min at room temperature. Photos of random fields were taken at 20x magnification with Zeiss Observer Z1 inverted microscope.</p>
</sec>
<sec>
<title><italic>In vitro</italic> Mechanical Stimulation of SVPs</title>
<p>To investigate the effect of mechanical strain on cultured cells, SVPs were subjected to cyclic strain using the FlexCell Tension Plus FX-5000T system. Before cell seeding, six-well uniaxial Bioflex plates were surface-coated with human fibronectin (10&#x003BC;g/ml) in PBS after covalent crosslinking with a crosslinking reagent (sulfosuccinimidyl 6-(4&#x00027;-azido-2&#x00027;-nitrophenylamino) hexanoate; Sulfo-SANPAH) at 0.2 mg/ml in Hepes 50 mM (pH 8.5), photo-activated by exposure to UV-light (365 nm). Cells were subjected to uniaxial cyclic deformation protocol (0&#x02013;10% deformation, 1 Hz frequency), for 24 and 72 h [according to a protocol established in (<xref ref-type="bibr" rid="B19">19</xref>)], while static controls were provided by seeding an equal amount of cells, under the same atmospheric conditions, but without mechanical stimulation (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 2A,B</xref>). For imaging of mechanically stimulated SVPs, cells were fixed after 72 h of uniaxial cyclic straining with 4% PFA in PBS, and thereafter stained with Phalloidin-TRITC (1:500, Sigma) and DAPI 1&#x003BC;g/ml (Thermo Fisher Scientific) at room temperature for 1 h.</p>
</sec>
<sec>
<title>Total RNA Isolation</title>
<p>For RNA-Seq analysis, total RNA was extracted from 5 different donors using RNeasy Mini kit (Qiagen). Cultured SVPs, approximately 4&#x000D7;10<sup>5</sup> to 5&#x000D7;10<sup>5</sup> cells per well, were resuspended in 700 &#x003BC;l of QIAzol Lysis Reagent (Qiagen) and residual DNA was removed by on-column DNase digestion. Total RNA was purified following the manufacturer&#x00027;s instructions and quantified by using NanoDrop-1000 spectrophotometer before integrity assessment with Agilent 2100 Bioanalyzer (RNA Integrity Number values &#x0003E;8).</p>
</sec>
<sec>
<title>RNA-Seq on <italic>in vitro</italic> Mechanical Stimulated SVPs</title>
<p>Next-generation sequencing experiments, including samples quality control and bioinformatics analysis, were performed by Genomix4life S.R.L. (Baronissi, Salerno, Italy). Indexed libraries were prepared from 500 ng/ea purified RNA with TruSeqStranded total RNA Sample Prep Kit (Illumina) according to the manufacturer&#x00027;s instructions. Libraries were quantified using the Agilent 2100 Bioanalyzer (Agilent Technologies) and Qubit fluorometer (Invitrogen Co.), then pooled such that each index-tagged sample was present in equimolar amounts, with a final concentration of the pooled samples of 2 nM. The pooled samples were subject to cluster generation and sequencing using an Illumina HiSeq 2,500 System (Illumina) in a 2 &#x000D7; 100 paired-end format at a final concentration of 8 pmol. The raw sequence files generated (.fastq files) underwent quality control analysis using FastQC (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>) and the quality checked reads were trimmed with cutadapt v.1.10 and then aligned to the human genome (hg38 assembly) using STAR v.2.5.2, with standard parameters. Differentially expressed mRNAs were identified using DESeq2 v.1.12. Gene annotation was obtained for all known genes in the human genome, as provided by GenCode (GRCh38.p7 release 25). Using the reads mapped to the genome, we calculated the number of reads mapping to each transcript with HT Seq-count v.0.6.1. These raw read counts were then used as input to DESeq2 for calculation of normalized signal for each transcript in the samples, and differential expression was reported as Fold Change along with associated adjusted <italic>p</italic>-values (computed according to Benjamini-Hochberg). Raw data of RNA-Seqthat support the findings of this publication have been deposited in NCBI&#x00027;s Gene Expression Omnibus (<xref ref-type="bibr" rid="B22">22</xref>) and are accessible through GEO Series accession number GSE192712 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE192712">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE192712</ext-link>).</p>
</sec>
<sec>
<title>RNA-Seq Data Pre-processing and Analysis</title>
<p>Upon inspection of quality control features with FastQC (version 0.11.8) [Andrews (2010). FastQC: a quality control tool for high throughput sequence data. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc">http://www.bioinformatics.babraham.ac.uk/projects/fastqc</ext-link>] and MultiQC (version 1.8), the raw sequencing reads were trimmed to remove adaptor contaminations, using Cutadapt (version 1.18) with the following parameters: cutadapt-a AGATCGGAAGAGCACACGTCTGAACTCCAGTCA -A AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT &#x02013;trim-n &#x02013;pair-filter=any &#x02013;minimum-length 20. Genome contamination screening was performed through FastQ Screen (version v0.14.0). The sequencing reads were, then, aligned to GENCODE&#x00027;s human reference genome (GRCh38 primary assembly v31) and quantified at the gene level using STAR (version2.7.3a), with default parameters and allowing up to 3 mismatches.</p>
<p>Evaluation of sequencing alignment data was performed through Qualimap application (v.2.2.2-dev) (<xref ref-type="bibr" rid="B23">23</xref>), using the following analysis types: Multi-sample BAM QC, RNA-seq QC, and Counts QC.</p>
<p>RNA-Seq analysis was performed using DESeq2 package (version 1.22.2) (<xref ref-type="bibr" rid="B24">24</xref>) in the R software (version 3.6.3) [R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>]. Samples were normalized for sequencing depth and RNA composition according to DESeq2 median of ratios method. Differential gene expression analysis was performed on genes that passed genefilter/DESeq2 independent filtering procedure (alpha = 0.05). Genes showing a BH-adjusted <italic>p</italic>-value &#x02264; 0.05 and log2FoldChange &#x0003E; 1.5 or log2FoldChange &#x0003C; &#x02212;1.5 were considered differentially expressed (DEGs).</p>
<p>For visualization purposes, counts were transformed using DESeq2 regularized log-transformation. DESeq2 plotPCA function was used for PCA analysis. Samples correlations were computed using the cor.dat function from the stats package (version 3.6.3). Heatmaps were plotted using the pheatmap package (version 1.0.12) [RaivoKolde (2019). pheatmap: Pretty Heatmaps. R package version 1.0.12. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=pheatmap">https://CRAN.R-project.org/package=pheatmap</ext-link>] and volcano plots with the EnhancedVolcano package (version 1.4.0) [Kevin Blighe, Sharmila Rana and Myles Lewis (2019). EnhancedVolcano: Publication-ready volcano plots with enhanced coloring and labeling. R package version 1.4.0. <ext-link ext-link-type="uri" xlink:href="https://github.com/kevinblighe/EnhancedVolcano">https://github.com/kevinblighe/EnhancedVolcano</ext-link>] (BH-adjusted <italic>p</italic>-value cutoff = 0.05, FC cutoff = 1.5).</p>
<p>Motif-based TF prediction was performed in Cytoscape (version 3.8.0) running iRegulon App (<xref ref-type="bibr" rid="B25">25</xref>) on the complete set of differentially expressed genes in the dynamic vs. static conditions, with the following parameters: Motif collection = 10 K (9,713 PWMs), Track collection = 1,120 ChIP-seq tracks (ENCODE raw signals), min NEScore = 2, ROC threshold for AUC calculation (% = 3), max FDR = 0.05, Motif rankings database = 20 kb centered around TSS (7 species), Track rankings database = 20 kb centered around TSS (ChIP-seq derived).</p>
<p>DEGs from each contrast and the corresponding logFCs and adjusted <italic>p-</italic>values were uploaded to Ingenuity Pathways Analysis (IPA) software (version 60467501) (QIAGEN Inc.) (<xref ref-type="bibr" rid="B26">26</xref>). Core Analysis was performed using default settings: only protein-protein interaction networks, upstream regulators networks and Diseases and Biological Functions enriched pathways involving AMIGO2 were considered, along with evaluation of the IPA TGF-&#x003B2; signaling canonical pathway. Bubble plots were produced using ggplot2 package (version 3.3.2) [H. Wickham. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York, 2016.] in R.</p>
<p>Pathway enrichment analysis on DEGs at 24 h and 72 h was performed using Metascape (<xref ref-type="bibr" rid="B27">27</xref>) (Express Analysis), only pathways involving AMIGO2 gene were considered.</p>
</sec>
<sec>
<title>Porcine <italic>in vivo</italic> Model of Vein Graft Remodeling</title>
<p><italic>In vivo</italic> studies were performed with Large White-Landrace cross pigs (weight 25 to 30 kg) using the saphenous vein-to-carotid artery interposition grafting model previously described (<xref ref-type="bibr" rid="B28">28</xref>). This investigation was performed in accordance with the Home Office Guidance on the operation of the Animals (Scientific Procedures) Act 1986 (HMSO, London, UK; PPL numbers 30/2585 and 30/3064) and was compliant with the EU Directive 2010/63/EU and principles stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996).</p>
<p>The animals were subjected to unilateral or bilateral autologous saphenous vein (SV) into common carotid artery bypass grafting. In brief, pigs were anesthetized with ketamine (Ketaset, 100 mg/mL), intubated, and maintained on 1&#x02013;3% halothane under spontaneous ventilation. The animal was heparinized by intravenous administration of 100 IU/kg of heparin. The long saphenous vein was harvested from the hind leg using the &#x0201C;no touch&#x0201D; technique (<xref ref-type="bibr" rid="B29">29</xref>), rinsed in a saline solution containing 2 IU/ml heparin and 50 &#x003BC;g/ml glyceryl trinitrate, and stored in the same solution at room temperature until needed. A 3-cm length of the vein was placed as an interposition graft to the internal carotid artery using continuous 7/0 Surgipro sutures. The flow was re-established and checked using a hand-held Doppler flow meter (Multidoplex II (model MD2), Huntleigh Diagnostics Ltd, Cardiff, UK), and the animals were given antibiotic (ampicillin) and analgesic (buprenorphine) before and during recovery. The pigs were anesthetized and the SV grafts were collected at the established time points (1, 3, 7, 14, and 90 days), followed by euthanasia using an intra-cardiac overdose of pentobarbital. The grafts were fixed in 4% paraformaldehyde for 16 h and then embedded in paraffin for immunohistochemical analyses. Paraffin-embedded tissue sections were dehydrated and after blocking with 6% BSA for 1 h, incubated for 16 h at 4&#x000B0;C with the primary antibodies: AMIGO2 (1:100, Abcam ab84416) and &#x003B1;-SMA (1:150, Dako M0851) to enable the identification between the medial and adventitial layer. Subsequently, sections were incubated with appropriate secondary antibodies diluted 1:200 for1 h at room temperature. Nuclei were stained with DAPI 1&#x003BC;g/ml for 10 min at room temperature. Digital images were obtained using an ApoTome fluorescence microscope or LSM-710 confocal scanning microscope (both Carl Zeiss, Germany). Cells positive for AMIGO2, counted in 3 fields <italic>per</italic> section, were expressed as a percentage of cells in the whole adventitia. Measurements and quantifications were performed using ImageJ (version 1.46r, National Institutes of Health, USA). Differences between time points were analyzed in GraphPad Prism 5 using ANOVA with Newman-Keuls <italic>post hoc</italic> test, with a significance level of 0.05.</p>
</sec>
<sec>
<title><italic>Ex vivo</italic> Mechanical Stimulation of Human SV</title>
<p>SV segments for <italic>ex vivo</italic> culture were supplied from the Department of Cardiovascular Surgery at Centro Cardiologico Monzino. The veins were obtained from patients undergoing coronary artery bypass operations under protocols approved by the Ethical Committees of the Centro Cardiologico Monzino (Italy). Mechanical stimulation of SVs was performed using a custom-made bioreactor tailored to reproduce the coronary mechanics. SV were harvested with a &#x0201C;no-touch&#x0201D; technique (<xref ref-type="bibr" rid="B7">7</xref>) and stored at 4&#x000B0;C in DMEM supplemented with 10% FBS, 1% L-Glutamine, and 1% P/S. The <italic>ex vivo</italic> culture system exploited for veins stimulation was designed by Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano and Unit&#x000E0; di Ingegneria Tissutale of Centro Cardiologico Monzino-IRCCS in Milan (<xref ref-type="bibr" rid="B30">30</xref>). This culture system allowed mimicking the arterial-like stimulation with a circumferential strain applied to the SV wall typical of the coronary circulation (<xref ref-type="bibr" rid="B31">31</xref>). Briefly, the arterial-like flow is accomplished in 4 independent phases: i) a loading step, ii) a pulsatile stimulation step, iii) an unloading step, and iv) a recirculation step. In the first phase, the vessel is filled with DMEM, 10% FBS, 1% L-Glutamine, and 1% P/S. During the pulsatile step, the medium is put under oscillating pressure between 80 mmHg and 120 mmHg and in the third phase the medium flows out of the vessels. The fourth phase is necessary to replace the medium inside the vein, thus maintaining stable nutrients and oxygen supply (<xref ref-type="bibr" rid="B17">17</xref>). The culture system was placed in a standard incubator at 37&#x000B0;C in a 5% CO 2 atmosphere and for a culture period of 14 days. Then, SV segments were un-mounted from the culture system, fixed in formalin 37% for 16 h, and then embedded in paraffin for immunohistochemical analyses. In brief, tissue sections were subjected to heat-induced antigen retrieval with 10 mM Sodium Citrate buffer pH 6.0 at 94&#x000B0;C for 30 min. Non-specific binding was blocked with 20% goat serum (Sigma-Aldrich) for 30 min at room temperature. Following the elimination of excess serum, the sections were exposed to the unconjugated primary antibodies at 4&#x000B0;C for 16 h:CD34 (1:50, R&#x00026;D AF7227), AMIGO2 (1:200, Abcam ab84416), CD31 (1:50, R&#x00026;D BBA7). After washing in PBS, the appropriate fluorescent secondary antibody (Alexa Fluor) diluted 1:200 in PBS was added to the cells for 60 min at 37&#x000B0;C. Nuclei were stained with DAPI (Thermo Fisher Scientific)1 &#x003BC;g/ml for 10 min at room temperature. Photos were taken at 20x magnification with Zeiss Observer Z1 inverted microscope and reconstructed using Photoshop (Adobe) to obtain the adventitia-lumen image.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Cyclic Uniaxial Strain Induces Changes in the Transcriptome of Human SVPs</title>
<p>To assess the effect of mechanical stress on SVP transcriptome, we subjected cells to cyclic uniaxial strain (defined as dynamic, dyn, from now on) for 24 and 72 h compared to standard culture (static, stat) and performed RNA-Seq. This <italic>in vitro</italic> system allowed us to identify the early alterations in the transcription, underscoring the mechanisms associated. First, we conducted an unsupervised clustering of the results based on the top 100 most variables expressed genes in the different culture conditions. This analysis and principal component analysis (PCA) showed no stretch-related groupings among replicates (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 3A,B</xref>). However, since the sequencing depth allowed us to quantify the expression of 28,624 genes that represent &#x0003C;50% of the ones annotated for <italic>Homo sapiens</italic> and include genes expressed at low levels, results may be non-consistent when performing differential expression analysis. Therefore, we next conducted a selection of genes expressed at reliable levels according to DESeq2 independent filtering procedure. The four datasets resulting from this filtering were paired in four comparisons to perform the differential expression analysis as follows: 1) 24 h dyn vs. 24 h stat, and 2) 72 h dyn vs. 72 h stat assessed the effect of strain at the two different time points 24 and 72 h; 3) 72 h stat vs. 24 h stat, and 4) 72 h dyn vs. 24 h dyn evaluated the effect of time on the culture conditions. These comparisons led to the following number of differentially expressed genes (DEGs): 1) 103 DEGs (24 hdyn vs. 24 h stat), 2) 819 DEGs (72 h dyn vs. 72 h stat), 3) 245 DEGs (72 h stat vs. 24 h stat), and 4) 72 DEGs in (72 h dyn vs. 24 h dyn) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>). We used hierarchical cluster analysis to assess the relationships between the DEGs in the four experimental conditions (<xref ref-type="fig" rid="F1">Figure 1</xref>). As shown, the heatmaps built using the four different datasets indicated a major prevalence of DEGs in the static vs. dynamic conditions at 72 h. In addition, coherent differential regulation of genes was already observed at an earlier time point in dynamically strained vs. control cells for 24 h (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Moreover, a time-dependent effect both in static and dynamic conditions was observed (<xref ref-type="fig" rid="F1">Figures 1B,C</xref>). The higher number of DEGs resulting from the comparison between dynamic <italic>vs</italic>. static conditions at 72 h prompted us to further analyze the identity of the top-score genes up/downmodulated in this specific condition and to explore whether these genes were represented already at the earlier time point (24 h of stimulation). To this aim, we listed the 10 most up-regulated and the 10 most down-regulated genes in the 72 h dyn vs. 72 h stat condition (<xref ref-type="table" rid="T1">Table 1</xref>). These genes can be easily visualized in a volcano plot displaying the 819 DEGs arranged by fold change and Benjamini-Hochberg (BH)-adjusted <italic>p</italic>-value (<xref ref-type="fig" rid="F2">Figure 2</xref>), they all had significantly higher expression (at least 1.5-fold more) than static controls along with a significant <italic>p</italic>-value (BH-adjusted <italic>p</italic>-value &#x02264; 0.05). In addition, <xref ref-type="table" rid="T2">Table 2</xref> shows the top regulated DEGs in the 24 h dyn vs. 24 h stat conditions. Only five genes were present in the top regulated lists at both time points representing candidates consistently regulated by mechanical stress in SVPs: Adhesion Molecule with Ig Like Domain 2 (<italic>AMIGO2</italic>), Serine/threonine-protein kinase 38-like (<italic>STK38L)</italic>, Caveolae Associated Protein 4 (<italic>CAVIN4)</italic>, Growth differentiation factor 5 (<italic>GDF5)</italic> and Polypeptide N-acetylgalactosaminyltransferase 15 (<italic>GALNT15)</italic> (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Hierarchical clustering in the four comparisons. <bold>(A)</bold> Heatmap representation showing 103 DEGs in 24 h dyn vs. 24 h stat. <bold>(B)</bold> Heatmap representation showing 245 DEGs in 72 h stat vs. 24 h stat. <bold>(C)</bold> Heatmap representation showing 72 DEGs in 72 h dyn vs. 24 h dyn. <bold>(D)</bold> Heatmap representation showing 819 DEGs in 72 h dyn vs. 72 h stat. For all heatmaps BH-adjusted <italic>p</italic>-value &#x02264; 0.05.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0001.tif"/>
</fig>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Top scored DEGs 72 h dyn vs. 72 h stat.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Top10 up-regulated DEGs &#x02013; 72 h ON vs. 72 h OFF</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Top10 down-regulated DEGs &#x02013; 72 h ON vs. 72 h OFF</bold></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>Log<sub><bold>2</bold></sub>FoldChange</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value BH-adjusted</bold></th>
<th valign="top" align="center"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>Log<sub><bold>2</bold></sub>FoldChange</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value BH-adjusted</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">SKIL</td>
<td valign="top" align="center">2.05</td>
<td valign="top" align="center">2.35E-23</td>
<td valign="top" align="center">MRVI1</td>
<td valign="top" align="center">&#x02212;3.69</td>
<td valign="top" align="center">1.84E-17</td>
</tr>
<tr>
<td valign="top" align="left">ENC1</td>
<td valign="top" align="center">2.19</td>
<td valign="top" align="center">1.82E-17</td>
<td valign="top" align="center">GDF5</td>
<td valign="top" align="center">&#x02212;2.92</td>
<td valign="top" align="center">6.60E-15</td>
</tr>
<tr>
<td valign="top" align="left">AMIGO2</td>
<td valign="top" align="center">5.66</td>
<td valign="top" align="center">2.14E-12</td>
<td valign="top" align="center">LOMD1</td>
<td valign="top" align="center">&#x02212;3.39</td>
<td valign="top" align="center">1.04E-14</td>
</tr>
<tr>
<td valign="top" align="left">BHLHE40</td>
<td valign="top" align="center">1.91</td>
<td valign="top" align="center">4.50E-12</td>
<td valign="top" align="center">VCAM1</td>
<td valign="top" align="center">&#x02212;4.51</td>
<td valign="top" align="center">2.52E-10</td>
</tr>
<tr>
<td valign="top" align="left">F2RL1</td>
<td valign="top" align="center">3.35</td>
<td valign="top" align="center">9.19E-12</td>
<td valign="top" align="center">KCNS2</td>
<td valign="top" align="center">&#x02212;3.08</td>
<td valign="top" align="center">2.79E-10</td>
</tr>
<tr>
<td valign="top" align="left">TGFB1</td>
<td valign="top" align="center">1.66</td>
<td valign="top" align="center">2.58E-11</td>
<td valign="top" align="center">GALNT15</td>
<td valign="top" align="center">3.91</td>
<td valign="top" align="center">5.39E-10</td>
</tr>
<tr>
<td valign="top" align="left">CAVIN4</td>
<td valign="top" align="center">3.33</td>
<td valign="top" align="center">3.55E-11</td>
<td valign="top" align="center">ATP2B4</td>
<td valign="top" align="center">&#x02212;1.70</td>
<td valign="top" align="center">1.87E-09</td>
</tr>
<tr>
<td valign="top" align="left">STK38L</td>
<td valign="top" align="center">1.63</td>
<td valign="top" align="center">9.84E-11</td>
<td valign="top" align="center">MBNL3</td>
<td valign="top" align="center">&#x02212;1.87</td>
<td valign="top" align="center">2.53E-09</td>
</tr>
<tr>
<td valign="top" align="left">DACT1</td>
<td valign="top" align="center">3.51</td>
<td valign="top" align="center">5.39E-10</td>
<td valign="top" align="center">DTNA</td>
<td valign="top" align="center">&#x02212;1.90</td>
<td valign="top" align="center">1.18E-08</td>
</tr>
<tr>
<td valign="top" align="left">IL11</td>
<td valign="top" align="center">3.91</td>
<td valign="top" align="center">1.04E-09</td>
<td valign="top" align="center">SNCG</td>
<td valign="top" align="center">&#x02212;1.70</td>
<td valign="top" align="center">3.58E-08</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Top regulated genes after 72 h of mechanical strain. Volcano plot showing significant genes in the 72 h dyn vs. 72 h stat comparison. The top 10 upregulated and down regulated DEGs are highlighted. Genes are colored if they pass the thresholds for BH-adjusted <italic>p</italic>-value and/or LogFC (blue if BH-adjusted <italic>p</italic>-value &#x02264; 0.05, green if logFC &#x0003C; &#x02212;1.5 or logFC&#x0003E; 1.5, red if they pass both thresholds).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0002.tif"/>
</fig>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Top scored DEGs 24 h dyn vs. 24 h stat.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Top10 up-regulated DEGs &#x02013; 24 h ON vs. 24 h OFF</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Top10 down-regulated DEGs &#x02013; 24 h ON vs. 24 h OFF</bold></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>Log<sub><bold>2</bold></sub>FoldChange</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value BH-adjusted</bold></th>
<th valign="top" align="center"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>Log<sub><bold>2</bold></sub>FoldChange</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value BH-adjusted</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">CAVIN4</td>
<td valign="top" align="center">2.91</td>
<td valign="top" align="center">1.23E-04</td>
<td valign="top" align="center">ACKR4</td>
<td valign="top" align="center">&#x02212;2.32</td>
<td valign="top" align="center">1.23E-04</td>
</tr>
<tr>
<td valign="top" align="left">AMIGO2</td>
<td valign="top" align="center">4.49</td>
<td valign="top" align="center">1.23E-04</td>
<td valign="top" align="center">GALNT15</td>
<td valign="top" align="center">&#x02212;2.55</td>
<td valign="top" align="center">5.76E-04</td>
</tr>
<tr>
<td valign="top" align="left">EDN1</td>
<td valign="top" align="center">2.91</td>
<td valign="top" align="center">1.58E-04</td>
<td valign="top" align="center">ANKRD33B</td>
<td valign="top" align="center">&#x02212;2.48</td>
<td valign="top" align="center">8.57E-03</td>
</tr>
<tr>
<td valign="top" align="left">KIA A 1755</td>
<td valign="top" align="center">2.68</td>
<td valign="top" align="center">4.60E-04</td>
<td valign="top" align="center">PDE7B</td>
<td valign="top" align="center">&#x02212;1.55</td>
<td valign="top" align="center">1.46E-02</td>
</tr>
<tr>
<td valign="top" align="left">MIR503HG</td>
<td valign="top" align="center">2.73</td>
<td valign="top" align="center">5.75E-04</td>
<td valign="top" align="center">IFIT1</td>
<td valign="top" align="center">&#x02212;1.67</td>
<td valign="top" align="center">1.46E-02</td>
</tr>
<tr>
<td valign="top" align="left">SMAD7</td>
<td valign="top" align="center">1.58</td>
<td valign="top" align="center">7.37E-04</td>
<td valign="top" align="center">FAM107A</td>
<td valign="top" align="center">&#x02212;3.44</td>
<td valign="top" align="center">1.92E-02</td>
</tr>
<tr>
<td valign="top" align="left">TSPAN2</td>
<td valign="top" align="center">3.17</td>
<td valign="top" align="center">8.21E-04</td>
<td valign="top" align="center">TOX</td>
<td valign="top" align="center">&#x02212;1.76</td>
<td valign="top" align="center">2.89E-02</td>
</tr>
<tr>
<td valign="top" align="left">COL7A1</td>
<td valign="top" align="center">2.42</td>
<td valign="top" align="center">1.23E-03</td>
<td valign="top" align="center">CENPP</td>
<td valign="top" align="center">&#x02212;1.52</td>
<td valign="top" align="center">3.12E-02</td>
</tr>
<tr>
<td valign="top" align="left">STK38L</td>
<td valign="top" align="center">1.73</td>
<td valign="top" align="center">1.71E-03</td>
<td valign="top" align="center">ZNF367</td>
<td valign="top" align="center">&#x02212;1.74</td>
<td valign="top" align="center">3.80E-02</td>
</tr>
<tr>
<td valign="top" align="left">ANGPTL4</td>
<td valign="top" align="center">1.62</td>
<td valign="top" align="center">2.78E-03</td>
<td valign="top" align="center">GDF5</td>
<td valign="top" align="center">&#x02212;1.54</td>
<td valign="top" align="center">4.41E-02</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>DEGs consistently regulated by mechanical stress.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>Gene ID</bold></th>
<th valign="top" align="left"><bold>Function</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Log</bold><sub><bold><bold>2</bold></bold></sub><bold>FoldChange</bold></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th valign="top" align="center"><bold>24 h</bold></th>
<th valign="top" align="center"><bold>72 h</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">AMIGO2</td>
<td valign="top" align="center">347902</td>
<td valign="top" align="left">This gene encodes a cell receptor involved in axon extension and migration. Also described as a pro-survival factor in endothelial cells subjected to hypoxia and regulator of tumor cell adhesion and formation of metastases.</td>
<td valign="top" align="center"><bold>4.49</bold></td>
<td valign="top" align="center"><bold>5.66</bold></td>
</tr>
<tr>
<td valign="top" align="left">STK38L</td>
<td valign="top" align="center">23012</td>
<td valign="top" align="left">The encoded protein is a serine/threonine kinase 38 like, inmplicated in neuronal cytoskeletal development, neurite outgrowth and synaptic remodeling.</td>
<td valign="top" align="center"><bold>1.73</bold></td>
<td valign="top" align="center"><bold>1.63</bold></td>
</tr>
<tr>
<td valign="top" align="left">CAVIN4</td>
<td valign="top" align="center">347273</td>
<td valign="top" align="left">Cavin-4 protein modulates the morphology of formed caveolae, results activated the extracellular signal-regulated kinase pathway, influencing skeletal muscle differentiation, and to activate RhoA pathway, modulating cardiac function.</td>
<td valign="top" align="center"><bold>2.91</bold></td>
<td valign="top" align="center"><bold>3.33</bold></td>
</tr>
<tr>
<td valign="top" align="left">GDF5</td>
<td valign="top" align="center">8200</td>
<td valign="top" align="left">This is one of the earliest genes expressed in the embryonic joint interzone, fated to give rise to joint tissues. Gdf5-lineage mesenchymal stromal/stem cells are involved in cartilage repair.</td>
<td valign="top" align="center"><bold>&#x02212;1.54</bold></td>
<td valign="top" align="center"><bold>&#x02212;2.92</bold></td>
</tr>
<tr>
<td valign="top" align="left">GALNT15</td>
<td valign="top" align="center">117248</td>
<td valign="top" align="left">The encoded protein catalyzes the initial reaction in O-linked oligosaccharide biosynthesis</td>
<td valign="top" align="center"><bold>&#x02212;2.55</bold></td>
<td valign="top" align="center"><bold>&#x02212;3.9</bold></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Characterization of AMIGO2 Regulation Induced by Mechanical Stress in SVPs</title>
<p>Among the genes that appear to be involved in vascular biology/pathology, our interest focused on <italic>AMIGO2</italic>, a gene encoding for a cell surface type I transmembrane receptor, which is a member of a novel class of leucine-rich repeat (LRR) and Ig superfamily proteins (<xref ref-type="bibr" rid="B32">32</xref>). AMIGO2 was identified for the first time in 2003, as an adhesion molecule necessary for the development of the axonal tract of neurons (<xref ref-type="bibr" rid="B33">33</xref>). Later, numerous other studies have reported AMIGO2 expression in gastrointestinal tract cancers, revealing its anti-apoptotic and cell adhesion activities which bestow to the tumor cells a higher metastasis formation capacity (<xref ref-type="bibr" rid="B34">34</xref>&#x02013;<xref ref-type="bibr" rid="B38">38</xref>). Therefore, considering that cell adhesion and migration are two of the main mechanisms involved in the reorganization of the SV wall during the formation of the neointima, we explored the putative functions of AMIGO2 in mechanically stimulated SVPs and the signaling that may lie upstream of its differential expression at a transcriptional level.</p>
<p>First, we validated the RNA-Seq results using RT-qPCR on the same RNA pools used to perform the RNA-seq and on RNAs isolated from SVPs of different patients subjected to uniaxial strain. Results confirmed the overexpression of AMIGO2 in the SVPs when mechanically stimulated (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>RNA-seq validation. Bar graphs showing relative expression of <italic>AMIGO2</italic> in SVPs after mechanical stimulation assessed by real-time qPCR. <bold>(A)</bold> Analysis performed in the same samples of the RNA-Seq (<italic>N</italic> = 5); difference among groups are evaluated using one-way ANOVA for normal distributed values, based on the result of normality tests. <bold>(B)</bold> Analysis performed using SVPs obtained from a new set of donors (<italic>N</italic> = 7), statistical analysis conducted using Kruskal&#x02013;Wallis test for not normal distributed values, based on results from normality tests. Data are presented as mean &#x000B1; SEM of 2-ddCt vs static (Stat) condition of each time point, &#x0002A;<italic>p</italic> &#x0003C; 0.05 &#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.01 (<italic>t</italic>-test stat vs. dyn).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0003.tif"/>
</fig>
<p>We then investigated the regulation of <italic>AMIGO2</italic> in SVPs under mechanical stress by examining the DEGs in all data sets, taking into consideration the AMIGO2-associated expression processes, the interactions with other proteins, and the biological functions in which it is putatively involved. First, through iRegulon motif-based prediction we identified 8 transcription factors (TFs) potentially involved in <italic>AMIGO2</italic> expression regulation. Hierarchical clustering showed a partial grouping among SVPs samples after 24 h of strain, which becomes robust when considering the samples cultured for 72 h (<xref ref-type="fig" rid="F4">Figure 4</xref>). Interestingly, 5 out of 8 TFs were related to transforming growth factor &#x003B2; (TGF-&#x003B2;) pathways (<italic>RUNX1, PRDM1, SOX4, PPARG</italic>, and <italic>SMAD3</italic>), known for modulating mesenchymal phenotype acquisition (<xref ref-type="bibr" rid="B39">39</xref>&#x02013;<xref ref-type="bibr" rid="B43">43</xref>). The TF <italic>CBFB</italic> acts in coordination with <italic>RUNX1</italic> regulating the transcription of several genes, one of which is <italic>NOTCH3</italic> (<xref ref-type="bibr" rid="B44">44</xref>). <italic>FOXD1</italic> mediates gene expression of the cell during the reprogramming process (<xref ref-type="bibr" rid="B45">45</xref>). These activities combined with the negative effect of stretching on <italic>TEF</italic> expression suggest the switching of SVPs toward a proliferative phenotype (<xref ref-type="bibr" rid="B46">46</xref>). For a better understanding the effects of the mechanical stretching on the TGF-&#x003B2; pathway, we performed Ingenuity Pathway Analysis (IPA) at both 24 h dyn vs. 24 h stat (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref>) and 72 h dyn vs. 72 h stat conditions (<xref ref-type="fig" rid="F5">Figure 5</xref>). Through pathway enrichment analysis for TGF-&#x003B2; signaling at 72 h dyn vs. 72 h stat, we were able to identify 36 genes associated with the TGF-&#x003B2; pathway that were down-regulated and 45 genes up-regulated (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 5</xref>). To show relevant relationships between modulated genes we performed IPA analysis in the complete dataset. The topmost identified networks are shown in <xref ref-type="fig" rid="F6">Figures 6A,B</xref>. In both comparisons 24 h dyn vs. 24 h stat and 72 h dyn vs. 72 h stat, <italic>AMIGO2</italic> expression was predicted to be controlled by <italic>NR3C1</italic>, the human glucocorticoid receptor gene, and <italic>NEUROG1</italic>, a regulator of neural progenitors&#x00027; differentiation (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Connections were also found for the mesenchymal oncogenes <italic>FUS-DDIT3</italic> at both time points and for <italic>RASSF1</italic> at 72 h (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Transcription factors potentially regulating <italic>AMIGO2</italic>. Hierarchically clustered heatmap showing differentially expressed TFs, that are predicted to regulate AMIGO2. The motif-based TF prediction was performed using iRegulon on the complete set of DEGs at both time points.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0004.tif"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>TGF-&#x003B2; signaling pathway map 72 h dyn vs. 72 h stat condition. Network depicting the regulation of TGF-&#x003B2; signaling cascade at 72 h, as represented by IPA. The values underneath each protein (when expressed in the dataset) indicate respectively the logFC and the adjusted <italic>p</italic>-value from the DE analysis between 72 h dyn and 72 h stat.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0005.tif"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>AMIGO2 upstream regulators-gene interaction networks. <bold>(A)</bold> Network depicting <italic>AMIGO2</italic> upstream regulators predicted activity at 24 h (24 h dyn vs. 24 h stat). <bold>(B)</bold> Network depicting <italic>AMIGO2</italic> upstream regulators predicted activity at 72 h (72 h dyn vs. 72 h stat). The values underneath each gene (when expressed in the dataset) indicate respectively the logFC and the adjusted <italic>p</italic>-value from the DE analysis. AMIGO2 is circled in red.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0006.tif"/>
</fig>
</sec>
<sec>
<title>AMIGO2 Expression Is Associated With a Mechanical Strain-Mediated Phenotypic Shift in SVPs</title>
<p>To gain further insight into mechanical strain-associated changes in SVPs in relation to <italic>AMIGO2</italic> we analyzed the human protein-protein interaction networks by IPA (<xref ref-type="fig" rid="F7">Figures 7A,B</xref>). In the 24 h dyn vs. 24 h stat comparison, AMIGO2 was found connected to NFkB complex which was predicted up-regulated by the modulation of DEGs present in the network. After 72 h of culture, the specific modulation of several genes, including AMIGO2, suggested an interaction with Akt, which was predicted to be inhibited as a result of the stretch-dependent changes in the transcriptional profile of SVPs. This finding was in contrast with what has been reported in AMIGO2&#x00027;s activation mechanism in endothelial cells (ECs) (<xref ref-type="bibr" rid="B36">36</xref>), and suggests that in SVPs AMIGO2 could operate through different pathways, independent of PDK-Akt. Next, the effect of mechanical strain on the molecular and cellular functions of SVPs has been closely examined via Gene Ontology (GO) analysis of the 24 h dyn vs. 24 h stat and 72 h dyn vs. 72 h stat conditions. <xref ref-type="table" rid="T4">Table 4</xref> shows the top 5 enriched pathways involving AMIGO2. The topmost function in SVPs stretched cells was cell-matrix adhesion (<italic>p</italic>-value 7.72 &#x000D7; 10<sup>&#x02212;10</sup>), along with chemotaxis (<italic>p</italic>-value 6.92 &#x000D7; 10<sup>&#x02212;10</sup>) and cell-cell adhesion via plasma-membrane adhesion molecules (<italic>p</italic>-value 2.07 &#x000D7; 10<sup>&#x02212;10</sup>), describing a potential switching of the SVPs phenotype toward migration. Ultimately, diseases and biological function-related pathways involving AMIGO2 were obtained through IPA (<xref ref-type="fig" rid="F8">Figures 8A,B</xref>). We observed an increase in the number of functions identified prolonging mechanical stress from 24 to 72 h. For example, the Cell Death and Survival macro-category after 24 h addressed only the regulation of apoptosis and necrosis, but after 72 h we also detected activation of cell viability and cell survival pathways. Of note, the cancer-related biofunctions were the most associated with AMIGO2 at both time points, reflecting its potential role in tissue invasion and remodeling (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Thus, the investigations performed with iRegulon and IPA as well as the AMIGO2-related GO findings shed a light on how mechanical stress could produce a phenotypic switching in the SVPs, mediating their activation and increasing their responsiveness to modifications occurring in the extracellular environment.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><italic>AMIGO2-protein</italic> interaction networks. <bold>(A)</bold> Protein-protein interaction network involving AMIGO2, identified by IPA analysis (24 h dyn vs. 24 h stat). <bold>(B)</bold> Protein-protein interaction network involving AMIGO2, identified by IPA analysis (72 h dyn vs. 72 h stat). The values underneath each protein (when expressed in the dataset) indicate respectively the logFC and the adjusted <italic>p</italic>-value from the DE analysis. AMIGO2 is circled in red.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0007.tif"/>
</fig>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>AMIGO2 related pathways regulation.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Term</bold></th>
<th valign="top" align="left"><bold>Description</bold></th>
<th valign="top" align="center"><bold>&#x02013;Log10 value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">GO:0098742</td>
<td valign="top" align="left">Cell-cell adhesion via plasma-membrane adhesion molecules</td>
<td valign="top" align="center"><bold>2.07</bold></td>
</tr>
<tr>
<td valign="top" align="left">GO:0007160</td>
<td valign="top" align="left">Cell-matrix adhesion</td>
<td valign="top" align="center"><bold>7.72</bold></td>
</tr>
<tr>
<td valign="top" align="left">GO:0044089</td>
<td valign="top" align="left">Positive regulation of cellular component biogenesis</td>
<td valign="top" align="center"><bold>3.74</bold></td>
</tr>
<tr>
<td valign="top" align="left">GO:0006935</td>
<td valign="top" align="left">Chemotaxis</td>
<td valign="top" align="center"><bold>6.92</bold></td>
</tr>
<tr>
<td valign="top" align="left">GO:0051962</td>
<td valign="top" align="left">Positive regulation of nervous system development</td>
<td valign="top" align="center"><bold>4.88</bold></td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>AMIGO2 associated functions. <bold>(A)</bold> Bubbleplot portraying a selection of &#x0201C;Diseases and Biological Functions&#x0201D; enriched pathways involving AMIGO2 from IPA analysis, in the 24 h dyn vs. 24 h stat comparison. <bold>(B)</bold> Bubbleplot portraying a selection of &#x0201C;Diseases and Biological Functions&#x0201D; enriched pathways involving AMIGO2 from IPA analysis, in the 72 h dyn vs. 72 h stat comparison. Pathways are organized by macro-categories on the x-axis and ordered by -log<sub>10</sub>BH-adjusted <italic>p</italic>-value on the y-axis. The bubble size is proportional to the number of molecules involved in the pathway.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0008.tif"/>
</fig>
</sec>
<sec>
<title>Arterial-Like Mechanic of SV Induces an Increase of AMIGO2 Positive Cells Only in Long Term <italic>in vivo</italic> Model</title>
<p>Given that the cyclic mechanical stress on SVPs produced a significant overexpression of AMIGO2 at the transcription level, we explored the effect of pulsatile coronary flow on AMIGO2 protein expression. This was assessed in two experimental systems that we previously used to validate Thrombospondin-1 as a relevant target of mechanical stress in the human SV arterialization process (<xref ref-type="bibr" rid="B19">19</xref>). These consisted of an <italic>in vivo</italic> SV arterialization model, performed by surgical SV interposition into carotid arteries in pigs, and of direct stimulation of human SVs using a coronary pulse duplicator that allows reproducing the mechanical conditions of the coronary circulation <italic>in vitro</italic>. Immunofluorescence staining was used to quantify the percentage of AMIGO2 positive cells in pig SV native conduits (T0) and at 1, 7, 14, and 90 days after grafting into the carotid artery (<xref ref-type="fig" rid="F9">Figure 9A</xref>). &#x0003C;40% of the cells in the SV adventitia expressed AMIGO2 at T0 (37.13 &#x000B1; 5.84%, <italic>N</italic> = 3) (<xref ref-type="fig" rid="F9">Figure 9B</xref>). This percentage remained relatively unaffected during the following 7 days after surgery. On day 14, the percentage reached almost 70% of the total cells of the adventitia (69.35 &#x000B1; 3.52%, <italic>N</italic> = 4), but this was not statistically different from the previous time points. Only at day 90 post-surgery, we observed a significant increase of AMIGO2 positive cells compared to T0, day 1, and day 7. In addition, we successfully identified numerous AMIGO2 expressing cells in human SV, both in the untapped conduit (T0) and following the application of a pulsatile pressure regimen for 14 days in <italic>ex vivo</italic> culture (<xref ref-type="fig" rid="F9">Figure 9C</xref>). It is interesting to note that in both experiments AMIGO2 expression was not restricted to the adventitia layer, but was also detected in several cells in the tunica media, as well as ECs. Particularly significant was the detection of AMIGO2/CD34 positive cells in the proximity of the <italic>vasa vasorum</italic>, where the SVPs are normally localized (<xref ref-type="bibr" rid="B21">21</xref>). The quantification of AMIGO2 expression in SVs from 4 different donors did not highlight any significant difference in the comparison T0 vs. Day 14 (data not shown). These data consolidate AMIGO2 as an important effector in the response to pathologic mechanical stress. Thus, despite the early AMIGO2 upregulation driven by the mechanical strain at 24 and 72 h in the SVPs, the protein increase in the adventitia appears to be delayed when the entire vein wall undergoes pulsatile arterial flow.</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p>AMIGO2 expression in vein graft remodeling. <bold>(A)</bold> Confocal microscopy analysis of paraffin-embedded porcine SVs for AMIGO2 (red) expression, nuclei are labeled with DAPI. Scale bar indicates 20 &#x003BC;m. <bold>(B)</bold> Bar graphs showing the percentage of AMIGO2 positive cells in porcine SV adventitia after grafting into the carotid artery (T0: <italic>N</italic> = 3, Day 1: <italic>N</italic> = 3, Day 7: <italic>N</italic> = 5, Day 14: <italic>N</italic> = 4, Day 90: <italic>N</italic> = 5; all data shown as Mean &#x000B1; SEM, &#x0002A; = <italic>p</italic> &#x0003C; 0.05). <bold>(C)</bold> Confocal microscopy analysis of paraffin-embedded human SVs for CD34 (green), AMIGO2 (red), CD31 (white), nuclei are labeled with DAPI. Scale bar indicates 50 &#x003BC;m.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-09-884031-g0009.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study, we showed for the first time that mechanical strain specifically alters the transcriptomic profile of human SVPs. The validation of the identified molecules and the further investigation of the molecular mechanisms associated with vein arterialization in specific cells is fundamental to developing targeted preventive and curative strategies to combat the failure of bypass grafts.</p>
<p>The existing causal relationship between arterial hemodynamic and IH in vein grafts is long known and well-established (<xref ref-type="bibr" rid="B51">51</xref>). Experimental evidence demonstrated that when dissected veins are re-anastomosed to venous circulation they do not develop IH (<xref ref-type="bibr" rid="B52">52</xref>), while vein grafts transposed from the arterial circulation back to the venous flow exhibited the regression of IH (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>). Therefore, mechanical stress resulting from the coronary flow pattern is sufficient for the molecular setting of IH. Further validation of the detrimental role of coronary mechanical load on the integrity of the SV wall is provided by the significant reduction in IH and beneficial effects on vessel compliance exerted by external stenting or photochemical tissue passivation (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Recently we demonstrated the role of mechanical forces in the pathologic evolution of the human SV, identifying phenotypic switching of resident smooth muscle cells and the activation of TGF-b/Thrombospondin-1 signaling in the SV medial layer as the nexus between the fibrotic activation of vessel-resident cells and non-physiologic vessel perfusion (<xref ref-type="bibr" rid="B19">19</xref>). We also demonstrated that coronary flow mechanics endured by the SV induces progressive recruitment of SVPs from the adventitia and transition toward the medial layer. In the current study, we assessed the mechanical sensitivity of the SVPs themselves which, like resident smooth muscle cells, were responsive to mechanical stress and thus may participate in the pathologic programming of the vein wall.</p>
<p>Using a platform that enables us to perform uniaxial strain <italic>in vitro</italic>, we subjected human primary culture amplified SVPs to a cyclic elongation pattern with a nominal deformation (10%) and a frequency (1 Hz) compatible with the predicted uniaxial strain component acting in SV wall (<xref ref-type="bibr" rid="B19">19</xref>). We then conducted a genome-wide RNA-Seq analysis to observe whether this stimulus was sufficient to elicit a robust change in SVPs gene expression. Through the analysis of DEGs in the four comparisons, two times of stimulation (24/72 h) and two experimental conditions (static/dynamic), we identified the 72 h dyn vs. 72 h stat as the most powerful in terms of transcriptomic alterations, with 819 DEGs. Interestingly, the variation in the transcriptome of SVPs subjected to mechanical stimulation occurred progressively and led to the identification of a few transcripts that were robustly up/downmodulated by mechanical treatment, highlighting them as &#x0201C;top scores&#x0201D; in the differentially expressed genes with possible important roles in SV pathologic programming.</p>
<p>Interestingly, this transcriptomic alteration is SVP-specific and potentially occurs before the phenotypic changes induced by paracrine signaling (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Moreover, SVP response to mechanical strain is similar to what has been observed in smooth muscle cells and ECs when comparable mechanical stress was applied (<xref ref-type="bibr" rid="B56">56</xref>). Several studies have demonstrated that cyclic strain exerts an effect on cellular proliferation, but there is no agreement with regard of this effect increases or reduces cell mitosis (<xref ref-type="bibr" rid="B56">56</xref>). Our results showed the activation in SVPs of apoptosis and necrosis pathways after 24 h with the addition of necrosis of epithelial tissue, neuronal cell death, cell viability, and cell survival pathways after 72 h of mechanical stress. This rather conflicting data would require further analysis. However, in the physiological environment of SV subjected to arterial flow, the paracrine signaling seems to generate a positive effect on SVPs proliferation, mainly through TGF-&#x003B2; and TSP-1 (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>Among the DEGs, we found particularly interesting the upregulation of <italic>AMIGO2</italic> for its putative role in intercellular communication and cell migratory activity, one of the functions which appear to be activated in SVPs by mechanical straining. AMIGO2 was first described in the development and survival of the nervous system, although following studies discovered numerous activities related to its expression in different cell phenotypes (<xref ref-type="bibr" rid="B33">33</xref>&#x02013;<xref ref-type="bibr" rid="B38">38</xref>). AMIGO2 belongs to the leucine-rich repeat (LRR) protein superfamily. LRR proteins share a common structural framework of 20 to 30 amino acids rich in the hydrophobic amino acid leucine (<xref ref-type="bibr" rid="B57">57</xref>). This family includes intracellular, extracellular, and membrane proteins with a wide range of functions such as cell adhesion, signaling, extracellular matrix assembly, RNA processing, and immune response. AMIGO2 acts as a cell adhesion molecule involved in signal transduction and, like other LRR proteins, functions mainly through homophilic and heterophilic interactions with proteins of the same family, i.e. AMIGO and AMIGO3 (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B34">34</xref>). It has been reported that in ECs and in gastric adenocarcinoma cell lines the inhibition of AMIGO2 affected the ability to adhere to extracellular matrix components (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Moreover, Hossain et al. demonstrated the presence of <italic>AMIGO2</italic> in human microvascular ECs and pericytes, pointing to an interaction between these cells in vascular remodeling (<xref ref-type="bibr" rid="B58">58</xref>). In mechanically stressed SVPs the up-regulation of <italic>AMIGO2</italic> could confer a firmer adhesion to adhesion substrates but also enhance their sensitivity to modifications of the extracellular matrix. Since mechanical strain during IH induces the remodeling of LLR proteins (such as biglycan, versican, and decorin) (<xref ref-type="bibr" rid="B59">59</xref>&#x02013;<xref ref-type="bibr" rid="B62">62</xref>), AMIGO2 could participate in SVP migration across the SV wall as observed in our previous study. This hypothesis is further supported by our GO analysis performed to identify the top regulated molecular functions enriched with AMIGO2 showing that in stretched SVPs cell-matrix adhesion, chemotaxis, and cell-cell adhesion via plasma-membrane adhesion molecules pathways were significantly up-regulated compared to static cultures, and by our unpublished evidences showing that mechanically strained-SVPs have a higher migratory mobility (Garoffolo et al., in preparation). Moreover, this finding is coherent to the invasive behavior that <italic>AMIGO2</italic> expression provides to tumor cells in the formation of metastasis (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Furthermore, a protein belonging to the LLR family, TSP-1, was already described as SVP&#x00027;s migration drive r (<xref ref-type="bibr" rid="B19">19</xref>). Notably, motif-based prediction of TFs potentially regulating <italic>AMIGO2</italic> revealed the presence of 5 TFs involved in TGF-&#x003B2; pathway. Previous studies reported that arterial-mimicking pressure elevates the expression of TGF-&#x003B2; in the SV and that TGF-&#x003B2; directly influences both ECs and SVPs, increasing the expression of SMC/mesenchymal differentiation markers and proliferation (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B63">63</xref>). In addition, the presence of AMIGO2 positive cells in the tunica media and not only the adventitia of the <italic>ex vivo</italic> stimulated human SVs and of <italic>in vivo</italic> arterialized pig SVs strongly suggest the involvement of the protein in a fibrotic process of the vessel wall controlled by mechanical-dependent pathways. Finally, we believe it would be worthy to investigate if the proneuronal transcription factor NEUROG1 (<xref ref-type="bibr" rid="B64">64</xref>) and the glucocorticoid receptor NR3C1 (<xref ref-type="bibr" rid="B48">48</xref>) play a role in the SVPs differentiation toward intimal hyperplasia onset in the contest of mechanical stress.</p>
<p>In summary, our results concur to a better understanding of the mechanisms underlying the SV remodeling and reveal a novel target for future investigations. In particular, new studies are warranted to assess the regulation of <italic>AMIGO2</italic> within the combination of mechanical and paracrine stimuli, such as TGF-&#x003B2;, to support the relevance of mechanically activated pathways in the onset and the progression of vein graft disease.</p>
</sec>
<sec sec-type="data-availability" id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, GSE192712.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>This study was reviewed and approved by the Local Ethical Committee at Centro Cardiologico Monzino, IRCCS. All subjects gave their written informed consent to participate. The animal study was performed in accordance with the Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act 1986 (HMSO, London, UK; PPL numbers 30/2585 and 30/3064) and was compliant with the EU Directive 2020/63/EU and principles stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996).</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>DM, GG, AT, MR, and RV performed experiments and analyzed data. GC analyzed data. MP, PM, and GS conceived the study. DM and GS wrote the paper. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>Funding/financial support was obtained from the Italian Ministry of Health, Ricerca Corrente to the IRCCS MultiMedica and Ricerca Finalizzata 2011 (project code: RF-2011-02346867) and was also supported by the Heart Research UK grant &#x02018;Targeting pericytes for halting pulmonary hypertension in infants with congenital heart disease&#x02019; (R102602).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack><p>We would like to thank Genomix4Life S.r.l., especially the technical team, for their support.</p>
</ack><sec sec-type="supplementary-material" id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2022.884031/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2022.884031/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Head</surname> <given-names>SJ</given-names></name> <name><surname>Milojevic</surname> <given-names>M</given-names></name> <name><surname>Taggart</surname> <given-names>DP</given-names></name> <name><surname>Puskas</surname> <given-names>JD</given-names></name></person-group>. <article-title>Current practice of state-of-the-art surgical coronary revascularization</article-title>. <source>Circulation.</source> (<year>2017</year>) <volume>136</volume>:<fpage>1331</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.022572</pub-id><pub-id pub-id-type="pmid">28972063</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raja</surname> <given-names>SG</given-names></name> <name><surname>Haider</surname> <given-names>Z</given-names></name> <name><surname>Ahmad</surname> <given-names>M</given-names></name> <name><surname>Zaman</surname> <given-names>H</given-names></name></person-group>. <article-title>Saphenous vein grafts: To use or not to use?</article-title> <source>Hear Lung Circ.</source> (<year>2004</year>) <volume>13</volume>:<fpage>150</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.hlc.2004.03.013</pub-id><pub-id pub-id-type="pmid">16352186</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osgood</surname> <given-names>MJ</given-names></name> <name><surname>Hocking</surname> <given-names>KM</given-names></name> <name><surname>Voskresensky I</surname> <given-names>V</given-names></name> <name><surname>Li</surname> <given-names>FD</given-names></name> <name><surname>Komalavilas</surname> <given-names>P</given-names></name> <name><surname>Cheung-Flynn</surname> <given-names>J</given-names></name> <name><surname>Brophy</surname> <given-names>CM</given-names></name></person-group>. <article-title>Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.</article-title> <source>J Vasc Surg.</source> (<year>2014</year>). 60: 202&#x02013;11. <pub-id pub-id-type="doi">10.1016/j.jvs.2013.06.004</pub-id><pub-id pub-id-type="pmid">23911244</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Locker</surname> <given-names>C</given-names></name> <name><surname>Schaff H</surname> <given-names>V</given-names></name> <name><surname>Dearani</surname> <given-names>JA</given-names></name> <name><surname>Joyce</surname> <given-names>LD</given-names></name> <name><surname>Park</surname> <given-names>SJ</given-names></name> <name><surname>Burkhart</surname> <given-names>HM</given-names></name> <etal/></person-group>. <article-title>Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8,622 patients with multivessel disease</article-title>. <source>Circulation.</source> (<year>2012</year>) <volume>126</volume>:<fpage>1023</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.084624</pub-id><pub-id pub-id-type="pmid">22811577</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname> <given-names>N</given-names></name> <name><surname>Jeremy</surname> <given-names>JY</given-names></name></person-group>. <article-title>Pathophysiology of saphenous vein graft failure: A brief overview of interventions</article-title>. <source>Curr Opin Pharmacol.</source> (<year>2012</year>) <volume>12</volume>:<fpage>114</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2012.01.001</pub-id><pub-id pub-id-type="pmid">22321569</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallitt</surname> <given-names>EJW</given-names></name> <name><surname>Jevon</surname> <given-names>M</given-names></name> <name><surname>Hornick</surname> <given-names>PI</given-names></name></person-group>. <article-title>Therapeutics of Vein Graft Intimal Hyperplasia: 100 Years On</article-title>. <source>Ann Thorac Surg.</source> (<year>2007</year>) <volume>84</volume>:<fpage>317</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2007.02.035</pub-id><pub-id pub-id-type="pmid">17588453</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dashwood</surname> <given-names>MR</given-names></name> <name><surname>Tsui</surname> <given-names>JC</given-names></name></person-group>. <article-title>&#x0201C;No-touch&#x0201D; saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery: a journey from bedside to bench</article-title>. <source>Vascul Pharmacol.</source> (<year>2013</year>) <volume>58</volume>:<fpage>240</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2012.07.008</pub-id><pub-id pub-id-type="pmid">22967905</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>MG</given-names></name> <name><surname>Hagen</surname> <given-names>PO</given-names></name></person-group>. <article-title>Reprinted Article &#x0201C;pathophysiology of vein graft failure: a review</article-title>.&#x0201D; <italic>Eur J Vasc Endovasc Surg</italic>. (<year>2011</year>) 42. S19&#x02013;29. <pub-id pub-id-type="doi">10.1016/j.ejvs.2011.06.013</pub-id><pub-id pub-id-type="pmid">21855014</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouten</surname> <given-names>CVC</given-names></name> <name><surname>Dankers</surname> <given-names>PYW</given-names></name> <name><surname>Driessen-Mol</surname> <given-names>A</given-names></name> <name><surname>Pedron</surname> <given-names>S</given-names></name> <name><surname>Brizard</surname> <given-names>AMA</given-names></name> <name><surname>Baaijens</surname> <given-names>FPT</given-names></name></person-group>. <article-title>Substrates for cardiovascular tissue engineering</article-title>. <source>Adv Drug Deliv Rev.</source> (<year>2011</year>) <volume>63</volume>:<fpage>221</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2011.01.007</pub-id><pub-id pub-id-type="pmid">21277921</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malek</surname> <given-names>AM</given-names></name> <name><surname>Alper</surname> <given-names>SL</given-names></name> <name><surname>Izumo</surname> <given-names>S</given-names></name></person-group>. <article-title>Hemodynamic shear stress and its role in atherosclerosis</article-title>. <source>J Am Med Assoc.</source> (<year>1999</year>) <volume>282</volume>:<fpage>2035</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1001/jama.282.21.2035</pub-id><pub-id pub-id-type="pmid">10591386</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>MG</given-names></name> <name><surname>Klyachkin</surname> <given-names>ML</given-names></name> <name><surname>Dalen</surname> <given-names>H</given-names></name> <name><surname>Massey</surname> <given-names>MF</given-names></name> <name><surname>Svendsen</surname> <given-names>E</given-names></name> <name><surname>Hagen</surname> <given-names>PO</given-names></name></person-group>. <article-title>The integrity of experimental vein graft endothelium-implications on the etiology of early graft failure</article-title>. <source>Eur J Vasc Surg.</source> (<year>1993</year>) <volume>7</volume>:<fpage>156</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/S0950-821X(05)80756-X</pub-id><pub-id pub-id-type="pmid">8462704</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname> <given-names>NR</given-names></name> <name><surname>Salacinski</surname> <given-names>HJ</given-names></name> <name><surname>Edwards</surname> <given-names>A</given-names></name> <name><surname>Hamilton</surname> <given-names>G</given-names></name> <name><surname>Seifalian</surname> <given-names>AM</given-names></name></person-group>. <article-title>Compliance properties of conduits used in vascular reconstruction</article-title>. <source>Br J Surg.</source> (<year>2000</year>) <volume>87</volume>:<fpage>1516</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2168.2000.01566.x</pub-id><pub-id pub-id-type="pmid">11091239</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname> <given-names>DL</given-names></name></person-group>. <article-title>Acute vascular endothelial changes associated with increased blood velocity gradients</article-title>. <source>Circ Res.</source> (<year>1968</year>) <volume>22</volume>:<fpage>165</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.22.2.165</pub-id><pub-id pub-id-type="pmid">5639037</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newby</surname> <given-names>AC</given-names></name> <name><surname>Zaltsman</surname> <given-names>AB</given-names></name></person-group>. <article-title>Molecular mechanisms in intimal hyperplasia</article-title>. <source>J Pathol.</source> (<year>2000</year>) <volume>190</volume>:<fpage>300</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9896(200002)190:3&#x0003C;300::AID-PATH596&#x0003E;3.0.CO;2-I</pub-id><pub-id pub-id-type="pmid">10685064</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>AO</given-names></name> <name><surname>Caputo</surname> <given-names>M</given-names></name> <name><surname>Angelini</surname> <given-names>GD</given-names></name> <name><surname>George</surname> <given-names>SJ</given-names></name> <name><surname>Zakkar</surname> <given-names>M</given-names></name></person-group>. <article-title>Activation and inflammation of the venous endothelium in vein graft disease</article-title>. <source>Atherosclerosis.</source> (<year>2017</year>) <volume>265</volume>:<fpage>266</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2017.08.023</pub-id><pub-id pub-id-type="pmid">28865843</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Callaghan</surname> <given-names>CJ</given-names></name> <name><surname>Williams</surname> <given-names>B</given-names></name></person-group>. <article-title>Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGF-&#x003B2;1</article-title>. <source>Hypertension.</source> (<year>2000</year>) <volume>36</volume>:<fpage>319</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.36.3.319</pub-id><pub-id pub-id-type="pmid">10988258</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prandi</surname> <given-names>F</given-names></name> <name><surname>Piola</surname> <given-names>M</given-names></name> <name><surname>Soncini</surname> <given-names>M</given-names></name> <name><surname>Colussi</surname> <given-names>C</given-names></name> <name><surname>D&#x00027;Alessandra</surname> <given-names>Y</given-names></name> <name><surname>Penza</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Adventitial vessel growth and progenitor cells activation in an ex vivo culture system mimicking human saphenous vein wall strain after coronary artery bypass grafting</article-title>. <source>PLoS ONE.</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0117409</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0117409</pub-id><pub-id pub-id-type="pmid">25689822</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGeachie</surname> <given-names>J</given-names></name> <name><surname>Campbell</surname> <given-names>P</given-names></name> <name><surname>Prendergast</surname> <given-names>F</given-names></name></person-group>. <article-title>Vein to artery grafts. A quantitative study of revascularization by vasa vasorum and its relationship to intimal hyperplasia</article-title>. <source>Ann Surg.</source> (<year>1981</year>) <volume>194</volume>:<fpage>100</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/00000658-198107000-00018</pub-id><pub-id pub-id-type="pmid">7247528</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garoffolo</surname> <given-names>G</given-names></name> <name><surname>Ruiter</surname> <given-names>MS</given-names></name> <name><surname>Piola</surname> <given-names>M</given-names></name> <name><surname>Brioschi</surname> <given-names>M</given-names></name> <name><surname>Thomas</surname> <given-names>AC</given-names></name> <name><surname>Agrifoglio</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Coronary artery mechanics induces human saphenous vein remodelling via recruitment of adventitial myofibroblast-like cells mediated by thrombospondin-1</article-title>. <source>Theranostics.</source> (<year>2020</year>) <volume>10</volume>:<fpage>2597</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.7150/thno.40595</pub-id><pub-id pub-id-type="pmid">32194822</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salinas</surname> <given-names>HM</given-names></name> <name><surname>Khan</surname> <given-names>SI</given-names></name> <name><surname>McCormack</surname> <given-names>MC</given-names></name> <name><surname>Fernandes</surname> <given-names>JR</given-names></name> <name><surname>Gfrerer</surname> <given-names>L</given-names></name> <name><surname>Watkins</surname> <given-names>MT</given-names></name> <name><surname>Redmond</surname> <given-names>RW</given-names></name> <name><surname>Austen</surname> <given-names>WG</given-names></name></person-group>. <article-title>Prevention of vein graft intimal hyperplasia with photochemical tissue passivation</article-title>. <source>J Vasc Surg</source>. (<year>2017</year>) <volume>65</volume>:<fpage>190</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2015.11.049</pub-id><pub-id pub-id-type="pmid">27066947</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campagnolo</surname> <given-names>P</given-names></name> <name><surname>Cesselli</surname> <given-names>D</given-names></name> <name><surname>Al Haj Zen</surname> <given-names>A</given-names></name> <name><surname>Beltrami</surname> <given-names>AP</given-names></name> <name><surname>Kr&#x000E4;nkel</surname> <given-names>N</given-names></name> <name><surname>Katare</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential</article-title>. <source>Circulation.</source> (<year>2010</year>) <volume>121</volume>:<fpage>1735</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.899252</pub-id><pub-id pub-id-type="pmid">20368523</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>R</given-names></name> <name><surname>Domrachev</surname> <given-names>M</given-names></name> <name><surname>Lash</surname> <given-names>AE</given-names></name></person-group>. <article-title>Gene expression omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res.</source> (<year>2002</year>) <volume>30</volume>:<fpage>207</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id><pub-id pub-id-type="pmid">11752295</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname> <given-names>P</given-names></name> <name><surname>Magnusson</surname> <given-names>M</given-names></name> <name><surname>Lundin</surname> <given-names>S</given-names></name> <name><surname>K&#x000E4;ller</surname> <given-names>M</given-names></name></person-group>. <article-title>MultiQC: Summarize analysis results for multiple tools and samples in a single report</article-title>. <source>Bioinformatics.</source> (<year>2016</year>) <volume>32</volume>:<fpage>3047</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw354</pub-id><pub-id pub-id-type="pmid">27312411</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name> <name><surname>Huber</surname> <given-names>W</given-names></name> <name><surname>Anders</surname> <given-names>S</given-names></name></person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol.</source> (<year>2014</year>) <volume>15</volume>:<fpage>550</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janky</surname> <given-names>R</given-names></name> <name><surname>Verfaillie</surname> <given-names>A</given-names></name> <name><surname>Imrichov&#x000E1;</surname> <given-names>H</given-names></name> <name><surname>van de Sande</surname> <given-names>B</given-names></name> <name><surname>Standaert</surname> <given-names>L</given-names></name> <name><surname>Christiaens</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections</article-title>. <source>PLoS Comput Biol.</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1003731</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003731</pub-id><pub-id pub-id-type="pmid">25058159</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000E4;mer</surname> <given-names>A</given-names></name> <name><surname>Green</surname> <given-names>J</given-names></name> <name><surname>Pollard</surname> <given-names>J</given-names></name> <name><surname>Tugendreich</surname> <given-names>S</given-names></name></person-group>. <article-title>Causal analysis approaches in ingenuity pathway analysis</article-title>. <source>Bioinformatics.</source> (<year>2014</year>) <volume>30</volume>:<fpage>523</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt703</pub-id><pub-id pub-id-type="pmid">24336805</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y</given-names></name> <name><surname>Zhou</surname> <given-names>B</given-names></name> <name><surname>Pache</surname> <given-names>L</given-names></name> <name><surname>Chang</surname> <given-names>M</given-names></name> <name><surname>Khodabakhshi</surname> <given-names>AH</given-names></name> <name><surname>Tanaseichuk</surname> <given-names>O</given-names></name> <etal/></person-group>. <article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title>. <source>Nat Commun.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id><pub-id pub-id-type="pmid">30944313</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Angelini</surname> <given-names>GD</given-names></name> <name><surname>Bryan</surname> <given-names>AJ</given-names></name> <name><surname>Williams</surname> <given-names>HMJ</given-names></name> <name><surname>Morgan</surname> <given-names>R</given-names></name> <name><surname>Newby</surname> <given-names>AC</given-names></name></person-group>. <article-title>Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts</article-title>. <source>J Thorac Cardiovasc Surg.</source> (<year>1990</year>) <volume>99</volume>:<fpage>433</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5223(19)36973-9</pub-id><pub-id pub-id-type="pmid">2308361</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>AC</given-names></name> <name><surname>Wyatt</surname> <given-names>MJ</given-names></name> <name><surname>Newby</surname> <given-names>AC</given-names></name></person-group>. <article-title>Reduction of early vein graft thrombosis by tissue plasminogen activator gene transfer</article-title>. <source>Thromb Haemost.</source> (<year>2009</year>) <volume>102</volume>:<fpage>145</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1160/TH08-11-0772</pub-id><pub-id pub-id-type="pmid">19572079</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piola</surname> <given-names>M</given-names></name> <name><surname>Ruiter</surname> <given-names>M</given-names></name> <name><surname>Vismara</surname> <given-names>R</given-names></name> <name><surname>Mastrullo</surname> <given-names>V</given-names></name> <name><surname>Agrifoglio</surname> <given-names>M</given-names></name> <name><surname>Zanobini</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Full mimicking of coronary hemodynamics for ex-vivo stimulation of human saphenous veins</article-title>. <source>Ann Biomed Eng.</source> (<year>2017</year>) <volume>45</volume>:<fpage>884</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1007/s10439-016-1747-7</pub-id><pub-id pub-id-type="pmid">27752921</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piola</surname> <given-names>M</given-names></name> <name><surname>Prandi</surname> <given-names>F</given-names></name> <name><surname>Bono</surname> <given-names>N</given-names></name> <name><surname>Soncini</surname> <given-names>M</given-names></name> <name><surname>Penza</surname> <given-names>E</given-names></name> <name><surname>Agrifoglio</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>compact and automated ex vivo vessel culture system for the pulsatile pressure conditioning of human saphenous veins</article-title>. <source>J Tissue Eng Regen Med.</source> (<year>2016</year>) <volume>10</volume>:<fpage>E204</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/term.1798</pub-id><pub-id pub-id-type="pmid">23897837</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuja-Panula</surname> <given-names>J</given-names></name> <name><surname>Kiiltom&#x000E4;ki</surname> <given-names>M</given-names></name> <name><surname>Yamashiro</surname> <given-names>T</given-names></name> <name><surname>Rouhiainen</surname> <given-names>A</given-names></name> <name><surname>Rauvala</surname> <given-names>H</given-names></name> </person-group>. <article-title>AMIGO a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats</article-title>. <source>J Cell Biol.</source> (<year>2003</year>) <volume>160</volume>:<fpage>963</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200209074</pub-id><pub-id pub-id-type="pmid">12629050</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname> <given-names>T</given-names></name> <name><surname>Sekino-Suzuki</surname> <given-names>N</given-names></name> <name><surname>Kikkawa</surname> <given-names>Y</given-names></name> <name><surname>Yonekawa</surname> <given-names>H</given-names></name> <name><surname>Kawashima</surname> <given-names>S</given-names></name></person-group>. <article-title>Alivin 1, a novel neuronal activity-dependent gene, inhibits apoptosis and promotes survival of cerebellar granule neurons</article-title>. <source>J Neurosci.</source> (<year>2003</year>) <volume>23</volume>:<fpage>5887</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-13-05887.2003</pub-id><pub-id pub-id-type="pmid">12843293</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rabenau</surname> <given-names>KE</given-names></name> <name><surname>O&#x00027;Toole</surname> <given-names>JM</given-names></name> <name><surname>Bassi</surname> <given-names>R</given-names></name> <name><surname>Kotanides</surname> <given-names>H</given-names></name> <name><surname>Witte</surname> <given-names>L</given-names></name> <name><surname>Ludwig</surname> <given-names>DL</given-names></name> <etal/></person-group>. <article-title>DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity</article-title>. <source>Oncogene.</source> (<year>2004</year>) <volume>23</volume>:<fpage>5056</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1207681</pub-id><pub-id pub-id-type="pmid">15107827</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsoi</surname> <given-names>LC</given-names></name> <name><surname>Qin</surname> <given-names>T</given-names></name> <name><surname>Slate</surname> <given-names>EH</given-names></name> <name><surname>Zheng</surname> <given-names>WJ</given-names></name></person-group>. <article-title>Consistent Differential Expression Pattern (CDEP) on microarray to identify genes related to metastatic behavior</article-title>. <source>Acta Vet Scand.</source> (<year>2011</year>) <volume>53</volume>:<fpage>438</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-12-438</pub-id><pub-id pub-id-type="pmid">22078224</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>H</given-names></name> <name><surname>Lee</surname> <given-names>S</given-names></name> <name><surname>Shrestha</surname> <given-names>P</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name> <name><surname>Park</surname> <given-names>JA</given-names></name> <name><surname>Ko</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation</article-title>. <source>J Cell Biol.</source> (<year>2015</year>) <volume>211</volume>:<fpage>619</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201503113</pub-id><pub-id pub-id-type="pmid">26553931</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanda</surname> <given-names>Y</given-names></name> <name><surname>Osaki</surname> <given-names>M</given-names></name> <name><surname>Onuma</surname> <given-names>K</given-names></name> <name><surname>Sonoda</surname> <given-names>A</given-names></name> <name><surname>Kobayashi</surname> <given-names>M</given-names></name> <name><surname>Hamada</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Amigo2-upregulation in tumour cells facilitates their attachment to liver endothelial cells resulting in liver metastases</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/srep43567</pub-id><pub-id pub-id-type="pmid">28272394</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>S</given-names></name> <name><surname>Kanda</surname> <given-names>M</given-names></name> <name><surname>Shimizu</surname> <given-names>D</given-names></name> <name><surname>Tanaka</surname> <given-names>C</given-names></name> <name><surname>Inokawa</surname> <given-names>Y</given-names></name> <name><surname>Hattori</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>AMIGO2 expression as a potential prognostic biomarker for gastric cancer</article-title>. <source>Anticancer Res.</source> (<year>2020</year>) <volume>40</volume>:<fpage>6713</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.21873/anticanres.14694</pub-id><pub-id pub-id-type="pmid">33288564</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>W</given-names></name> <name><surname>Barron</surname> <given-names>DA</given-names></name> <name><surname>Martin</surname> <given-names>RS</given-names></name> <name><surname>Chan</surname> <given-names>KS</given-names></name> <name><surname>Tran</surname> <given-names>LL</given-names></name> <name><surname>Yang</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation</article-title>. <source>Proc Natl Acad Sci U S A.</source> (<year>2014</year>) <volume>111</volume>:<fpage>13389</fpage>&#x02013;<lpage>6394</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1407097111</pub-id><pub-id pub-id-type="pmid">25313057</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romagnoli</surname> <given-names>M</given-names></name> <name><surname>Belguise</surname> <given-names>K</given-names></name> <name><surname>Yu</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Landesman-Bollag</surname> <given-names>E</given-names></name> <name><surname>Seldin</surname> <given-names>DC</given-names></name> <etal/></person-group>. <article-title>Epithelial-to-mesenchymal transition induced by TGF-&#x003B2;1 is mediated by blimp-1-dependent repression of BMP-5</article-title>. <source>Cancer Res.</source> (<year>2012</year>) <volume>72</volume>:<fpage>6268</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-2270</pub-id><pub-id pub-id-type="pmid">23054396</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>G</given-names></name> <name><surname>Peng</surname> <given-names>H</given-names></name> <name><surname>Chen</surname> <given-names>A</given-names></name> <name><surname>Zha</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name></person-group>. <article-title>SOX4 contributes to TGF-&#x003B2;-induced epithelial&#x02013;mesenchymal transition and stem cell characteristics of gastric cancer cells</article-title>. <source>Genes Dis.</source> (<year>2018</year>) <volume>5</volume>:<fpage>49</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.gendis.2017.12.005</pub-id><pub-id pub-id-type="pmid">30258935</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>SG</given-names></name> <name><surname>Kim</surname> <given-names>HA</given-names></name> <name><surname>Jong</surname> <given-names>HS</given-names></name> <name><surname>Park</surname> <given-names>JH</given-names></name> <name><surname>Kim</surname> <given-names>NK</given-names></name> <name><surname>Hong</surname> <given-names>SH</given-names></name> <etal/></person-group>. <article-title>The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3</article-title>. <source>Mol Biol Cell.</source> (<year>2005</year>) <volume>16</volume>:<fpage>4672</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e05-01-0054</pub-id><pub-id pub-id-type="pmid">16093355</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reka</surname> <given-names>AK</given-names></name> <name><surname>Kurapati</surname> <given-names>H</given-names></name> <name><surname>Narala</surname> <given-names>VR</given-names></name> <name><surname>Bommer</surname> <given-names>G</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Standiford</surname> <given-names>TJ</given-names></name> <etal/></person-group>. <article-title>Peroxisome proliferator-activated receptor-g activation inhibits tumor metastasis by antagonizing smad3-mediated epithelial-mesenchymal transition</article-title>. <source>Mol Cancer Ther.</source> (<year>2010</year>) <volume>9</volume>:<fpage>3221</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-10-0570</pub-id><pub-id pub-id-type="pmid">21159608</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname> <given-names>N</given-names></name> <name><surname>Yan</surname> <given-names>H</given-names></name> <name><surname>Moshkovich</surname> <given-names>N</given-names></name> <name><surname>Palangat</surname> <given-names>M</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Sanchez</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription</article-title>. <source>Nat Commun.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-10102-6</pub-id><pub-id pub-id-type="pmid">31061501</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname> <given-names>M</given-names></name> <name><surname>Matsuda</surname> <given-names>M</given-names></name> <name><surname>Kawamura</surname> <given-names>T</given-names></name> <name><surname>Sogo</surname> <given-names>T</given-names></name> <name><surname>Shigeno</surname> <given-names>A</given-names></name> <name><surname>Nishida</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Foxd1 is a mediator and indicator of the cell reprogramming process</article-title>. <source>Nat Commun.</source> (<year>2014</year>) <volume>5</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms4197</pub-id><pub-id pub-id-type="pmid">24496101</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Yuan</surname> <given-names>D</given-names></name> <name><surname>Zheng</surname> <given-names>S</given-names></name></person-group>. <article-title>Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway</article-title>. <source>Cell Prolif.</source> (<year>2019</year>) 52: e12560. <pub-id pub-id-type="doi">10.1111/cpr.12560</pub-id><pub-id pub-id-type="pmid">30515906</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palma-Gudiel</surname> <given-names>H</given-names></name> <name><surname>C&#x000F3;rdova-Palomera</surname> <given-names>A</given-names></name> <name><surname>Leza</surname> <given-names>JC</given-names></name> <name><surname>Fa&#x000F1;an&#x000E1;s</surname> <given-names>L</given-names></name></person-group>. <article-title>Glucocorticoid receptor gene (NR3C1) methylation processes as mediators of early adversity in stress-related disorders causality: a critical review</article-title>. <source>Neurosci Biobehav Rev.</source> (<year>2015</year>) <volume>55</volume>:<fpage>520</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.05.016</pub-id><pub-id pub-id-type="pmid">26073068</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>MuhChyi</surname> <given-names>C</given-names></name> <name><surname>Juliandi</surname> <given-names>B</given-names></name> <name><surname>Matsuda</surname> <given-names>T</given-names></name> <name><surname>Nakashima</surname> <given-names>K</given-names></name></person-group>. <article-title>Epigenetic regulation of neural stem cell fate during corticogenesis</article-title>. <source>Int J Dev Neurosci.</source> (<year>2013</year>) <volume>31</volume>:<fpage>424</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2013.02.006</pub-id><pub-id pub-id-type="pmid">23466416</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennani-Baiti</surname> <given-names>IM</given-names></name></person-group>. <article-title>Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis</article-title>. <source>Epigenomics.</source> (<year>2011</year>) <volume>3</volume>:<fpage>715</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.2217/epi.11.93</pub-id><pub-id pub-id-type="pmid">22126291</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x000E9;rez-Mancera</surname> <given-names>PA</given-names></name> <name><surname>S&#x000E1;nchez-Garc&#x000ED;a</surname> <given-names>I</given-names></name></person-group>. <article-title>Understanding mesenchymal cancer: The liposarcoma-associated FUS-DDIT3 fusion gene as a model</article-title>. <source>Semin Cancer Biol.</source> (<year>2005</year>) <volume>15</volume>:<fpage>206</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2005.01.006</pub-id><pub-id pub-id-type="pmid">15826835</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname> <given-names>CD</given-names></name></person-group>. <article-title>Adaptive changes in autogenous vein grafts for arterial reconstruction: Clinical implications</article-title>. <source>J Vasc Surg.</source> (<year>2010</year>) <volume>51</volume>:<fpage>736</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2009.07.102</pub-id><pub-id pub-id-type="pmid">19837532</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brody</surname> <given-names>WR</given-names></name> <name><surname>Angeli</surname> <given-names>WW</given-names></name> <name><surname>Kosek</surname> <given-names>JC</given-names></name></person-group>. <article-title>Histologic fate of the venous coronary artery bypass in dogs</article-title>. <source>Am J Pathol.</source> (<year>1972</year>) <volume>66</volume>:<fpage>111</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">5009248</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>MG</given-names></name> <name><surname>Fulton</surname> <given-names>GJ</given-names></name> <name><surname>Svendsen</surname> <given-names>E</given-names></name> <name><surname>Hagen</surname> <given-names>PO</given-names></name></person-group>. <article-title>Time course of the regression of intimal hyperplasia in experimental vein grafts</article-title>. <source>Cardiovasc Pathol.</source> (<year>1999</year>) <volume>8</volume>:<fpage>161</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S1054-8807(98)00029-5</pub-id><pub-id pub-id-type="pmid">10722239</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fann</surname> <given-names>JI</given-names></name> <name><surname>Sokoloff</surname> <given-names>MH</given-names></name> <name><surname>Sarris</surname> <given-names>GE</given-names></name> <name><surname>Yun</surname> <given-names>KL</given-names></name> <name><surname>Kosek</surname> <given-names>JC</given-names></name> <name><surname>Miller</surname> <given-names>DC</given-names></name></person-group>. <article-title>The reversibility of canine vein-graft arterialization</article-title>. <source>Circulation.</source> (<year>1990</year>) <volume>82</volume>:<fpage>IV9</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">2225440</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moodley</surname> <given-names>L</given-names></name> <name><surname>Franz</surname> <given-names>T</given-names></name> <name><surname>Human</surname> <given-names>P</given-names></name> <name><surname>Wolf</surname> <given-names>MF</given-names></name> <name><surname>Bezuidenhout</surname> <given-names>D</given-names></name> <name><surname>Scherman</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Protective constriction of coronary vein grafts with knitted nitinol</article-title>. <source>Eur J Cardio-thoracic Surg.</source> (<year>2013</year>) <volume>44</volume>:<fpage>64</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezs670</pub-id><pub-id pub-id-type="pmid">23295444</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riha</surname> <given-names>GM</given-names></name> <name><surname>Lin</surname> <given-names>PH</given-names></name> <name><surname>Lumsden</surname> <given-names>AB</given-names></name> <name><surname>Yao</surname> <given-names>Q</given-names></name> <name><surname>Chen</surname> <given-names>C</given-names></name></person-group>. <article-title>Roles of hemodynamic forces in vascular cell differentiation</article-title>. <source>Ann Biomed Eng.</source> (<year>2005</year>) <volume>33</volume>:<fpage>772</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s10439-005-3310-9</pub-id><pub-id pub-id-type="pmid">16078617</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bella</surname> <given-names>J</given-names></name> <name><surname>Hindle</surname> <given-names>KL</given-names></name> <name><surname>McEwan</surname> <given-names>PA</given-names></name> <name><surname>Lovell</surname> <given-names>SC</given-names></name></person-group>. <article-title>The leucine-rich repeat structure</article-title>. <source>Cell Mol Life Sci.</source> (<year>2008</year>) <volume>65</volume>:<fpage>2307</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-8019-0</pub-id><pub-id pub-id-type="pmid">18408889</pub-id></citation></ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname> <given-names>S</given-names></name> <name><surname>Ahmed</surname> <given-names>MU</given-names></name> <name><surname>Alam</surname> <given-names>S</given-names></name> <name><surname>Watanabe</surname> <given-names>A</given-names></name> <name><surname>Harashima</surname> <given-names>A</given-names></name> <name><surname>Yonekura</surname> <given-names>H</given-names></name> <name><surname>Yamamoto</surname> <given-names>H</given-names></name></person-group>. <article-title>Expressions and roles of AMIGO gene family in vascular endothelial cells</article-title>. <source>Int J Biosci Biochem Bioinforma.</source> (<year>2012</year>) <volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.7763/IJBBB.2012.V2.58</pub-id></citation>
</ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>L</given-names></name> <name><surname>Kerr</surname> <given-names>A</given-names></name> <name><surname>Haydock</surname> <given-names>D</given-names></name> <name><surname>Merrilees</surname> <given-names>M</given-names></name></person-group>. <article-title>Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlate with susceptibility to atherosclerosis</article-title>. <source>J Vasc Res.</source> (<year>1997</year>) <volume>34</volume>:<fpage>365</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1159/000159245</pub-id><pub-id pub-id-type="pmid">9349730</pub-id></citation></ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hocking</surname> <given-names>AM</given-names></name> <name><surname>Shinomura</surname> <given-names>T</given-names></name> <name><surname>McQuillan</surname> <given-names>DJ</given-names></name></person-group>. <article-title>Leucine-rich repeat glycoproteins of the extracellular matrix</article-title>. <source>Matrix Biol.</source> (<year>1998</year>) <volume>17</volume>:<fpage>1</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/S0945-053X(98)90121-4</pub-id><pub-id pub-id-type="pmid">9628249</pub-id></citation></ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>RT</given-names></name> <name><surname>Yamamoto</surname> <given-names>C</given-names></name> <name><surname>Feng</surname> <given-names>Y</given-names></name> <name><surname>Potter-Perigo</surname> <given-names>S</given-names></name> <name><surname>Briggs</surname> <given-names>WH</given-names></name> <name><surname>Landschulz</surname> <given-names>KT</given-names></name> <etal/></person-group>. <article-title>Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells</article-title>. <source>J Biol Chem.</source> (<year>2001</year>) <volume>276</volume>:<fpage>13847</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M010556200</pub-id><pub-id pub-id-type="pmid">11278699</pub-id></citation></ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenagy</surname> <given-names>RD</given-names></name> <name><surname>Kikuchi</surname> <given-names>S</given-names></name> <name><surname>Evanko</surname> <given-names>SP</given-names></name> <name><surname>Ruiter</surname> <given-names>MS</given-names></name> <name><surname>Piola</surname> <given-names>M</given-names></name> <name><surname>Longchamp</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Versican is differentially regulated in the adventitial and medial layers of human vein grafts</article-title>. <source>PLoS ONE.</source> (<year>2018</year>) <volume>13</volume>:<fpage>e0204045</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0204045</pub-id><pub-id pub-id-type="pmid">30265729</pub-id></citation></ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooley</surname> <given-names>BC</given-names></name> <name><surname>Nevado</surname> <given-names>J</given-names></name> <name><surname>Mellad</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>D</given-names></name> <name><surname>St Hilaire</surname> <given-names>C</given-names></name> <name><surname>Negro</surname> <given-names>A</given-names></name> <name><surname>Fang</surname> <given-names>F</given-names></name> <name><surname>Chen</surname> <given-names>G</given-names></name> <name><surname>San</surname> <given-names>H</given-names></name> <name><surname>Walts</surname> <given-names>AD</given-names></name> <etal/></person-group>. <article-title>TGF-&#x003B2; signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling</article-title>. <source>Sci Transl Med.</source> (<year>2014</year>) <volume>6</volume>:<fpage>227ra34</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3006927</pub-id><pub-id pub-id-type="pmid">24622514</pub-id></citation></ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Nadal-Vicens</surname> <given-names>M</given-names></name> <name><surname>Misono</surname> <given-names>S</given-names></name> <name><surname>Lin</surname> <given-names>MZ</given-names></name> <name><surname>Zubiaga</surname> <given-names>A</given-names></name> <name><surname>Hua</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms</article-title>. <source>Cell</source>. (<year>2001</year>) <volume>104</volume>:<fpage>365</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(01)00224-0</pub-id><pub-id pub-id-type="pmid">11239394</pub-id></citation></ref>
</ref-list> 
</back>
</article>
